During the past decade, Great Lakes Hemophilia Foundation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Great Lakes Hemophilia Foundation" #1 collaborator was "Bristol-Myers Squibb" with 5 trials as a collaborator and "Glaxo Wellcome" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Great Lakes Hemophilia Foundation" are "HIV Infections" (8 trials) and "Chickenpox" (1 trials). Many other conditions were trialed in "Great Lakes Hemophilia Foundation" in a lesser frequency.

Most popular intervention types in "Great Lakes Hemophilia Foundation" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Didanosine" (4 trials), "Zidovudine" (4 trials), "Indinavir sulfate" (2 trials), "Abacavir sulfate" (1 trials) and "Acyclovir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Great Lakes Hemophilia Foundation" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Great Lakes Hemophilia Foundation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Great Lakes Hemophilia Foundation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Great Lakes Hemophilia Foundation, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".